Peter Greenleaf sold $17K of Pelthos Therapeutics stock
By AlphaYouPublished Form 4
Greenleaf Peter
Reporting filer
Peter Greenleaf reported selling 797 shares of Pelthos Therapeutics Inc. for about $17K ($21.17 a share on average). Form 4 filed Oct 6, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Greenleaf Peter | 2026-10-02 | S | Sale | 797 | 21.17 | 23,087 | 4 days | Filed terms
|
Common Stock
- Owner
- Greenleaf Peter
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 797
- Price
- 21.17
- Following holdings
- 23,087
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 797
- transaction Price Per Share: 21.17
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 23087
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Greenleaf Peter: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
Original sources
Prepared automatically from public filing data. Report a correction.